Koch Strategic Platforms Leads $102M Series D Funding Investment in 6K To Accelerate Battery Material Production and Recycling
The investment is the first of two funding closes, expected to reach over $150M in total, aimed at building a low-cost, sustainable domestic supply chain for battery materials
GelSight will grow its presence in ten countries across Europe and Asia through four new distribution agreements
New financing will fuel international expansion and increase manufacturing capacity for its low power, sunlight-readable, and eye safe reflective LCD technology
Companies commence partnership to utilize NUBURU’s high power, high brightness blue laser technology and Essentium’s metal additive manufacturing platform to speed metal part production
CytoTronics Launches with $9.25 Million in Seed Funding to Revolutionize Drug Discovery and Phenotypic Screening
Harvard University spinout advances a unique complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform that opens a new dimension in cell-based screening
South 8 Technologies Raises $12M to Commercialize Next Generation Electrolytes for High Performance Lithium-ion Batteries
Financing from LG Technology Ventures, Shell Ventures, TNSC, Anzu Partners, and Foothill Ventures will help increase market adoption of the company’s proven Liquefied Gas Electrolyte technology
The financing will accelerate field validation and production of the BioTOF™ z200, a bio-aerosol detection system
Baker-Polito Administration Awards $1.5 Million Mass. Manufacturing Innovation Initiative Grant to North Andover’s 6K
Award from the Center for Advanced Manufacturing at MassTech will Fund High-Tech Equipment to Recycle Scrap Materials Used in Additive Manufacturing and Battery Production
InterVenn to Showcase Novel Translational Research Opportunities Based on Glycoproteomics at AACR 2022
InterVenn to Showcase Novel Translational Research Opportunities Based on Glycoproteomics at AACR 2022
e-Zinc Secures USD $25 Million in Series A Financing to Advance Long-Duration Energy Storage
Codetta Biosciences Announces $15 Million in Series A Financing
Funding will be utilized to expand commercial operations and support new product development
The new U.S. patent covers NTx’s inventive in vitro cell-free expression system that overcomes the cost and timeline challenges faced by traditional systems
Veteran Healthcare Executive and Reimbursement Expert Joins InterVenn Biosciences’ Board of Advisors
James Almas, MD, has joined the company’s Board of Advisors to advise on reimbursement strategy, health economics, coding, and other foundational activities required for commercialization of novel diagnostic tests for the clinical market.
Liquid Instruments Announces New Instruments and Enhancements for Moku:Go to Expand Use Cases and Transform Engineering Education
Moku:Go and Moku:Pro to Introduce New Capabilities and Improve Usability for Students, Scientists and Engineers
Three-time public company CFO joins NUBURU with deep experience in leading business transformation and optimization of financial processes on a global scale
OTI Lumionics and UBC Demonstrate Quantum Computing Methods to be Effective in Simulating OLED Display Material Properties
Published in Angewandte Chemie International Edition, researchers found that quantum computing methods can accurately predict the colour of light emission from OLED emitter materials
The new material, produced on 6K’s UniMelt® microwave plasma production system, will be used in ONE’s range-extended Gemini battery system.
Investment to accelerate next-generation Clean Earth Magnet™ development for use in hard disk drives for enterprise cloud storage, data centers and more
ImmunoScape will utilize Pure MHC’s library of T cell antigens specific to tumor cells to accelerate identification of novel T cell receptors using its Deep Immunomics platform
AML100 boosts battery life by up to 20x with innovative system-level approach to always-on power reduction
The AML100 boosts battery life by up to 20x with an innovative system-level approach to always-on power reduction
BioSkryb Genomics and ALS Automated Lab Solutions GmbH Sign U.S. Distribution Agreement to Power Unprecedented Single Cell Spatial Genomics
The agreement combines industry-leading technologies, enabling single cell selection and genome sequencing, and supports the development of intact tissue sample analysis
NTx Awarded Grant to Develop Novel Manufacturing Technologies for Improved Global Access to mRNA Vaccines and Therapeutics
NTx has received a grant from the Bill & Melinda Gates Foundation to develop new production approaches to lower the cost and improve access to mRNA vaccines and therapeutics for low- and middle-income countries
GelSight Expands its Board of Directors to Guide Transformation into Tactile Intelligence Platform Company
MAKO and Magic Leap founder Rony Abovitz and experienced executive and investor Elliot Katzman will help shape GelSight’s strategy and reach
First-in-human trial is now open for enrollment for EBT-101, a CRISPR-based therapeutic being developed as a potential functional cure for people living with HIV
Beyond Imagination and GelSight Announce Pilot to Pair State-of-the-art Tactile Sensing With Cutting-edge Telepresence Robotics
Beyond Imagination and GelSight have initiated a pilot to study the feasibility of using Beyond Imagination’s humanoid robotic technology to remotely operate GelSight’s tactile sensors.
Additional growth capital brings NUBURU’s valuation to approximately $350M and executive appointments will accelerate commercialization of its blue laser technology
InterVenn Promotes Klaus Lindpaintner to InterVenn Distinguished Scientist; Appoints Tillman Pearce as Chief Medical Officer
Klaus has served so far as the company’s Chief Medical and Scientific Officer and will now focus on serving as InterVenn’s scientific alliance ambassador to the global glycobiology constituency.
Mr. Liddy brings over 30 years of executive leadership, IPO and private equity experience, and board involvement with Abbott Laboratories, AbbVie, and Boeing to help guide NTx’s commercialization efforts
Albemarle to invest in 6K and sponsor development of UniMelt® system for advanced, sustainable materials production
This appointment brings peerless experience as a previous board member of Boeing, 3M, Abbott and Goldman Sachs to support 6K’s accelerated growth
First independent Battery Index provides the ‘missing link’ for manufacturers of battery-powered products from consumer electronics to EVs
Thall brings 30+ years of computer technology experience with Microsoft, Verizon and Visteon
Life sciences industry veteran brings decades of experience in public and private companies to scale the company’s capabilities and operations for accelerated growth
InterVenn Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022
InterVenn Biosciences is scheduled to present at the J.P. Morgan 40th Annual Healthcare Conference on January 12, 2022.
Share on twitter Share on linkedin WALTHAM, Mass.–(BUSINESS WIRE)–GelSight, a pioneer in tactile intelligence technology, announced today that it has been selected as a winner in Fast Company’s Next Big
InterVenn Presents Results Detailing Glycoproteomic Signature Predictive of Response to Immune Checkpoint Inhibitor Treatment in Advanced Non-Small Cell Lung Cancer at American Society for Immunotherapy of Cancer
Results presented on a predictive signature capable of identifying non-small cell lung cancer patients that will benefit most from immune checkpoint inhibitors.
GelSight will commercially manufacture the DIGIT sensor to increase access and enable new tactile applications in robotics and beyond
InterVenn Presents Results at American Society for Mass Spectrometry Conference Demonstrating that Differential Peripheral Blood Glycoproteomic Signatures are Associated with Symptomatic vs. Asymptomatic Course of COVID-19 Infection
Results on the application of its perspectIV™ platform in COVID-19 patients demonstrate that glycoproteomic profiles in patients with a severe course of the infection are significantly different from those who experienced an asymptomatic course of the infection.
Gary Hall joins 6K as Chief Financial Officer with over 20 years of experience leading finance and operational teams at high-growth, technology companies and helping these companies generate significant shareholder value through public and private offerings.
BioFlyte Appoints Former U.S. Ambassador and National Security Advisor John Bolton to Board of Directors
Ambassador Bolton brings decades of experience in national security, foreign policy, and diplomacy to BioFlyte as the company looks to expand its critical infrastructure business
Liquid Instruments introduces breakthrough customization capabilities in test equipment with Instrument-on-Chip architecture
Liquid Instruments delivers unprecedented flexibility in Test & Measurement with its latest software release, enabling advanced multi-instrument capabilities and customizable real-time signal processing.
Share on twitter Share on linkedin WALTHAM, Mass.–(BUSINESS WIRE)–GelSight, a pioneer in tactile imaging and sensing technology, today introduced the latest version of its GelSight Mobile™ probe, the Series 2.
Appointments include Sara Turken, J.D., as General Counsel, Manish Anand, M.Sc., as Senior Vice President, Regulatory Affairs, and Robert Gunning, CPA, CGMA, as VP, Controller
Move supports company’s multi-year strategic growth initiative; advances retention, attraction, and expansion of the team; enhances the ability to serve customers; and demonstrates Company’s commitment to the region
Share on twitter Share on linkedin NORTH ANDOVER, Mass., Sept. 28, 2021 /PRNewswire/ — 6K, an innovative leader in the production of sustainable advanced materials for energy storage and additive
Galderma Announces Exclusive Agreement With Sofregen to Develop the Next Generation of Biostimulator Fillers Using Silk-Based Technology
LAUSANNE, Switzerland & FRAMINGHAM, Mass.–(BUSINESS WIRE)–Galderma, the world’s largest independent dermatology company, and Sofregen Medical, Inc., a medical device company pioneering the use of silk protein for tissue building and
Gamma Biosciences Makes Strategic Investment in Process Analytics and Continuous Bioprocessing Company, Nirrin Technologies
Share on twitter Share on linkedin MENLO PARK, Calif. and BILLERICA, Mass., Sept. 23, 2021 /PRNewswire/ — Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced
Share on twitter Share on linkedin CAMBRIDGE, Mass.–(BUSINESS WIRE)–Adaptive Surface Technologies, Inc. (AST), a world leader in repellent surfaces, today announced it has entered into a new distribution partnership with
6K Raises $51M to Accelerate Advanced Battery Material Development and Global Expansion of Additive Manufacturing Powders
Share on twitter Share on linkedin North Andover, MA. Sept 22, 2021 – 6K, a leader in the production of sustainable advanced materials for energy storage and additive manufacturing powders,
Latest Media Coverage